Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

• Clinically studied curcumin formulation demonstrating significantly enhanced absorption versus standard 95% curcuminoid extracts.

• Derived predominantly from turmeric (~98.5%), maintaining a composition closer to the natural profile of the plant.

Utilizes a turmeric-derived ingredient described as self-affirmed GRAS and evaluated in published research showing up to 39× higher free curcumin bioavailability under study conditions.

CHICAGO, IL / ACCESS Newswire / April 17, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the planned Q2 2026 U.S. market launch of Cur18, a next-generation curcumin supplement, marking a further step in the Company's expansion into the U.S. nutraceutical market.

Cur18 enters the U.S. curcumin category as a science-driven alternative to conventional curcumin formulations, addressing one of the most fundamental limitations of the category: poor bioavailability. Based on published pharmacokinetic research, the formulation technology behind Cur18 has demonstrated significantly enhanced absorption, including up to 39× higher free curcumin bioavailability versus standard 95% curcuminoid extracts under study conditions.

The Bioavailability Problem with Conventional Curcumin

Curcumin is widely used for its antioxidant and anti-inflammatory properties, yet conventional curcumin formulations are known to have poor absorption. Because curcumin is hydrophobic, it does not dissolve efficiently in water-based environments and is often absorbed only to a limited extent in the digestive system. Curcumin's poor aqueous solubility and low oral bioavailability are well established in the literature.

Cur18 is designed to address this challenge through an advanced formulation approach that enhances the dispersion and absorption of curcuminoids, supporting improved bioavailability and more efficient delivery. The underlying ingredient profile is described as retaining essential oils and polar resins alongside curcuminoids, unlike standard 95% curcuminoid extracts that lose much of this native turmeric matrix during processing.

39× Higher free curcumin bioavailability than standard 95% curcuminoid extracts

49.5×